SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-18-000115
Filing Date
2018-12-12
Accepted
2018-12-12 07:01:21
Documents
18
Period of Report
2018-12-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kcorppresentation_121218.htm 8-K 26839
2 EXHIBIT 99.1 a20181212optinose.htm EX-99.1 19559
3 a20181212optinose001.jpg GRAPHIC 49891
4 a20181212optinose002.jpg GRAPHIC 241160
5 a20181212optinose003.jpg GRAPHIC 149309
6 a20181212optinose004.jpg GRAPHIC 114517
7 a20181212optinose005.jpg GRAPHIC 163582
8 a20181212optinose006.jpg GRAPHIC 138239
9 a20181212optinose007.jpg GRAPHIC 111286
10 a20181212optinose008.jpg GRAPHIC 30986
11 a20181212optinose009.jpg GRAPHIC 154227
12 a20181212optinose010.jpg GRAPHIC 143090
13 a20181212optinose011.jpg GRAPHIC 153678
14 a20181212optinose012.jpg GRAPHIC 122263
15 a20181212optinose013.jpg GRAPHIC 101240
16 a20181212optinose014.jpg GRAPHIC 148870
17 a20181212optinose015.jpg GRAPHIC 137100
18 optinoselogorgba16.jpg GRAPHIC 10067
  Complete submission text file 0001494650-18-000115.txt   2761521
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 181229997
SIC: 2834 Pharmaceutical Preparations